Skip to main content
Premium Trial:

Request an Annual Quote

Caroline Dorsa

Intellia Therapeutics has named Caroline Dorsa to its board of directors. Dorsa brings over 30 years of management experience in the energy, pharmaceuticals, and telecommunications industries.

Dorsa has previously held positions at Merck, where she was VP and Treasurer. Most recently, she was exectuive VP and CFO at the Public Service Enterprise Group. Dorsa also serves on the board of Biogen.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.